canakinumab

Summary

canakinumab is a type of chemical entity^[1]. canakinumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (45 views/month).^[2]

Key Facts

• canakinumab's instance of is recorded as type of chemical entity^[3].
• canakinumab is a type of chemical compound^[4].
• canakinumab is used for medication^[5].
• canakinumab's has characteristic is recorded as biopharmaceutical^[6].
• canakinumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'canakinumab'}^[7].
• canakinumab's subject has role is recorded as monoclonal antibody^[8].
• canakinumab's active ingredient in is recorded as Ilaris^[9].
• canakinumab's has active ingredient is recorded as Canakinumab^[10].
• canakinumab's defined daily dose is recorded as {'unit': 'Q3241121', 'amount': '+2.7'}^[11].
• canakinumab's LiverTox likelihood score is recorded as LiverTox toxicity likelihood category E*^[12].

Why It Matters

canakinumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (45 views/month).^[2] canakinumab has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.^[13] canakinumab is known by 4 alternative names across languages and contexts.^[14]